Insider Cluster (3 insiders) ·Filed Feb 23, 2026

ARVN

ARVINAS, INC.
BEARISH
Impact 5/10
Horizondays Processed7mo ago
Insider cluster: 3 insiders, $0.0M total
Actionable Insight ▼ Bearish

Monitor for follow-up filings or commentary — coordinated C-suite selling may signal lack of confidence, especially if not part of a pre-arranged plan. Check for 10b5-1 plans in future disclosures.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
ARVN ▼ -28.62% at T+60d
SHORT call ✓ call won +28.62% · α vs SPY +36.87% · entry $12.30 → $8.78
Entry anchored
Feb 20, 03:59 PM ET
via exchange tick
T+1d
+0.57%
call -0.57% · α +0.17%
$12.37
settled 7mo ago
T+5d
+8.86%
call -8.86% · α -8.24%
$13.39
settled 7mo ago
T+20d
-16.10%
call +16.10% · α +12.15%
$10.32
settled 7mo ago
T+60d
-28.62%
call +28.62% · α +36.87%
$8.78
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Three top executives at Arvinas — including the CEO, Chief Scientific Officer, and Chief Accounting Officer — each sold approximately 1,038 shares in a coordinated open-market transaction on February 23, 2026, totaling $38,717 in sales. This represents a rare instance of multiple C-suite executives selling shares simultaneously, suggesting a shared motivation such as portfolio diversification or liquidity needs.

Key Financial Metrics

Direction
selling
Total Value
$38.7K
Insiders
3

Key Facts

  • CEO Randy Teel sold 1,038 shares for $12,622.08
  • Chief Scientific Officer Angela Cacace sold 1,038 shares for $12,622.08
  • Chief Accounting Officer David Loomis sold 1,108 shares for $13,473.28
  • All sales occurred on the same day at $12.16 per share
  • Total insider selling cluster: $38,717 across 3 executives

Financial Impact

$38,717 in insider sales over one day

insider ownershipinvestor sentimentshareholder dilution risk

Risk Factors

  • Perceived negative signal from multiple executives selling at once
  • Potential misinterpretation if sales were pre-planned under 10b5-1

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (3 trades, 7d window)cluster-ARVN-1772109077022
18 reports for ARVN
Performance horizon
100% Hit rate 8 of 8 directional calls best @ T+20▲ +27.06%May 12, 2026
Filters
Rows
Reports for ARVN — sortable, filterable
TypeNow
Sep 4, 2026
28d ago
144
NEUTRAL ★ 3/10
$9.08 $8.26▼ −9.03%▼ −7.91%$7.41 (−18.39%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$8.14 $8.29▲ +1.84%▲ +0.83%$7.41 (−8.97%)
Jun 2, 2026
17w ago
8-K
BEARISH ★ 6/10
$7.70 $6.98▲ +9.35%▲ +5.53%$7.41 (+3.77%)
May 12, 2026
20w ago
8-K
MIXED ★ 6/10
$9.57 $8.78▼ −8.26%▼ −8.33%$7.41 (−22.57%)
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$9.57 $8.78▼ −8.26%▼ −8.33%$7.41 (−22.57%)
May 12, 2026
20w ago
Press Release
BEARISH ★ 8/10
$9.57 $8.78▲ +8.26%▲ +8.33%$7.41 (+22.57%)
May 8, 2026
20w ago
144
NEUTRAL ★ 2/10
$9.66 $8.78▼ −9.11%▼ −9.02%$7.41 (−23.29%)
May 8, 2026
20w ago
144
NEUTRAL ★ 2/10
$9.66 $8.78▼ −9.11%▼ −9.02%$7.41 (−23.29%)
May 5, 2026
21w ago
Press Release
BEARISH ★ 7/10
$10.61 $9.57▲ +9.80%▲ +11.79%$7.41 (+30.16%)
May 1, 2026
22w ago
8-K
BULLISH ★ 8/10
$10.51 $10.19▼ −3.04%▼ −5.39%$7.41 (−29.50%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Feb 26, 2026